Literature DB >> 10385544

An analysis of two versus three grades for endometrial carcinoma.

R R Taylor1, J Zeller, R W Lieberman, D M O'Connor.   

Abstract

Introduction. The current grading of uterine endometrioid adenocarcinoma utilizes a three-grade system based on the amount of nonsquamous solid histologic architecture. Of these three grades, we questioned the practical clinical utility of the intermediate grade. Methods. We retrospectively reviewed endometrial biopsy and uterine histology specimens, quantifying the percentage amount of nonsquamous solid tumor by intervals of 10. We then compared these percentage values to other histopathologic prognostic variables. Results. Eighty-five Stage I and II endometrioid adenocarcinoma patients had their preoperative endometrial curettings and operative hysterectomy pathology reviewed independently by two gynecologic pathologists for surgical staging and outcome with a mean follow-up of 6 years. Using a two-tiered system for assessing uterine tumor grade with a delineating value of 20% nonsquamous solid tumor, we found less interobserver variation (kappa = 0.966) compared to the current three-tiered grading system (kappa = 0.526). There were no differences between the two- and three-tiered grading systems regarding myometrial invasion, lymph vascular space invasion, and survival. In the diagnosis of endometrial biopsies, the two-tiered system also improved the prediction of uterine histology grade over the three-tiered system, 90 and 63%, respectively. Conclusion. A two-grade architecture system with a delineation value of 20% would be more reliable and less cumbersome and would have the same or better prognostic significance as the currently used three-grade system.

Entities:  

Mesh:

Year:  1999        PMID: 10385544     DOI: 10.1006/gyno.1999.5422

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  5 in total

1.  Prognostic significance of solid growth in endometrioid endometrial adenocarcinoma.

Authors:  Serra Akar; Zeliha Esin Çelik; Sıddıka Fındık; Tolgay Tuyan İlhan; Fedi Ercan; Çetin Çelik
Journal:  Int J Clin Oncol       Date:  2019-08-26       Impact factor: 3.402

Review 2.  Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR).

Authors:  W Glenn McCluggage; Meagan J Judge; Blaise A Clarke; Ben Davidson; C Blake Gilks; Harry Hollema; Jonathan A Ledermann; Xavier Matias-Guiu; Yoshiki Mikami; Colin J R Stewart; Russell Vang; Lynn Hirschowitz
Journal:  Mod Pathol       Date:  2015-06-19       Impact factor: 7.842

3.  The pattern of myometrial invasion as a predictor of lymph node metastasis or extrauterine disease in low-grade endometrial carcinoma.

Authors:  Elizabeth Euscher; Patricia Fox; Roland Bassett; Hayma Al-Ghawi; Rouba Ali-Fehmi; Denise Barbuto; Bojana Djordjevic; Elizabeth Frauenhoffer; Insun Kim; Sun Rang Hong; Delia Montiel; Elizabeth Moschiano; Andres Roma; Elvio Silva; Anais Malpica
Journal:  Am J Surg Pathol       Date:  2013-11       Impact factor: 6.394

Review 4.  [Grading of gynecological tumors : Current aspects].

Authors:  L-C Horn; D Mayr; C E Brambs; J Einenkel; I Sändig; K Schierle
Journal:  Pathologe       Date:  2016-07       Impact factor: 1.011

5.  Interobserver agreement for endometrial cancer characteristics evaluated on biopsy material.

Authors:  S Nofech-Mozes; N Ismiil; V Dubé; R S Saad; Z Ghorab; A Grin; I Ackerman; M A Khalifa
Journal:  Obstet Gynecol Int       Date:  2012-02-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.